Cora Health covers denosumab therapy for Basildon and Brentwood patients
- NHS Essex Integrated Care Board
- East of England
- Below threshold - without competition
- 15 April 2026 to 30 June 2026
NHS Essex Integrated Care Board hired Cora Health to keep denosumab therapy going for patients in Basildon and Brentwood. Primary care could not take the work on as soon as planned, so the board awarded it directly as an urgent measure.
Cora Health was to treat about 100 to 150 current patients over six weeks. It also had to complete shared care paperwork for about 700 patients not having injections then. That paperwork was to go to primary care in date order, ready for each patient's injection.
Prices were £53 for denosumab therapy and £20 for each patient record. The £20,000 contract ran from April 2026 and was due to end in June 2026.
- What
- GP locally commissioned and enhanced services
- Supplier
- Cora Health
- Value
- £20,000
- How it was bought
- Below threshold - without competition
- Dates and next
- Apr 2026 to Jun 2026